The Future of mRNA Platforms: Strategic Pause or Premature Pivot?
نویسندگان
1 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;
doi
10.30476/ijms.2025.108672.4367چکیده
The last month’s decision by the U.S. Department of Health and Human Services (HHS) to withdraw nearly $500 million from mRNA vaccine research and development (R&D) has aroused concern in the scientific and medical communities.
